111 Inc: Gains on BeiGene tie-up to create oncology management platform
17/03/2021 11:19
** U.S.-listed shares of China-based Internet medical and
health co YI.O up 3.68% at $18.6 premarket
** Co enters into a strategic cooperation agreement with
biotech co BeiGene Ltd 6160.HK BGNE.O urn:newsml:reuters.com:*:nPn3vV2jJa
** Two companies will cooperate around an "Internet +
Medicine & Healthcare" model to create an oncology management
platform
** BeiGene currently markets two oncology medicines in
China, BTK inhibitor, BRUKINSA (zanubrutinib), and anti-PD-1
antibody, tislelizumab
** YI has internet hospital supply chain network and
data-driven AI solutions, such as digital advertising, and
online/offline direct-to-patient delivery of medicines
** Last month, YI also inked an agreement with Jilin Baiyi
Doctor Group to deliver new models for internet medical services
urn:newsml:reuters.com:*:nPn407W9ta
** Up to last close, stock nearly doubled YTD
(Reporting by Rithika Krishna in Bengaluru)
((Rithika.Krishna@thomsonreuters.com;))